Sept 2013 GAO Study Calls for Clearer FDA Authority Over Compounders The Government Accountability Office (GAO) says in a new report that the FDA needs clearer authority over large compounding pharmacies, giving reform proponents a boost.

This article is viewable by subscribers only. To view this article, please select an option below.